Intelligent Medicine Acquisition Corp. (IQMD) Research

Intelligent Medicine Acquisition Corp. currently has no active business operations. Instead, its primary objective is to seek and finalize a merger, stock exchange, asset acquisition, or other form of business combination with one or more existing companies. The company specifically aims to identify promising business opportunities within the life science sector. Established in 2021, it operates out of Bethesda, Maryland.

Market snapshot

Symbol
IQMD
Price
$11.04
Day change
+7.71%
Market cap
$239.4M
P/E ratio
22.53x
52-week range
10.75-11.22
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • A SPAC II Acquisition Corporation (ASCB)
  • BYTE Acquisition Corp. (BYTS)
  • Cactus Acquisition Corp. 1 Limited (CCTS)
  • Chenghe Acquisition Co. (CHEA)
  • Currenc Group, Inc. (CURR)
  • Focus Impact Acquisition Corp. (FIAC)
  • Healthcare AI Acquisition Corp. (HAIA)
  • Industrial Tech Acquisitions II, Inc. (ITAQ)

Recent insider activity

  • GOLDMAN SACHS GROUP INC — trade (0 shares) on 2023-04-17
  • GOLDMAN SACHS GROUP INC — trade (1067 shares) on 2023-04-17
  • Saba Capital Management, L.P. — D-Return (2170581 shares) on 2023-02-24
  • Intelligent Medicine Sponsor LLC — G-Gift (200000 shares) on 2023-02-08
  • Saba Capital Management, L.P. — trade (0 shares) on 2022-05-05

Open Intelligent Medicine Acquisition Corp. (IQMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.